InsidersTradesSigma
Track the 圣诺生物 share price and the full management transaction log of the company, a publicly traded company based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 圣诺生物 has recorded 1 public disclosures. Market capitalisation: €5bn. The latest transaction was reported on 28 November 2022 (Sale). Among the most active insiders: 卢昌亮. All data is openly available.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€170
1 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 12,170 of 29,063 companies
56.1
score / 100
Value39
Quality73
FCF yld0.7%
Earn yld3.2%
EV/EBITDA21.1x
ROE17%
Gross mgn58%
Net mgn21%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 November 2022
关于 圣诺生物
圣诺生物是一家在上海证券交易所上市的医疗保健和制药公司。它专注于生物制药产品的开发和商业化。